David Lovejoy
Nessuna posizione attualmente
Patrimonio netto: 49 104 $ in data 31/05/2024
Storia della carriera di David Lovejoy
Precedenti posizioni note di David Lovejoy
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| University of Toronto | Corporate Officer/Principal | - | - |
| PROTAGENIC THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 03/02/1994 | - |
| Fondatore | 03/02/1994 | - | |
Protagenic Therapeutics, Inc. /Old/
 Protagenic Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Protagenic Therapeutics, Inc. discovers and develops neuropeptides for the treatment of anxiety and depression based mood disorders. It focuses on the discovery and development of naturally occurring human brain hormones for the treatment of anxiety and depression based mood disorders. The firm products include PT00114 and PT00121, which are peptide-based formulations for the treatment of anxiety and depression disorders. The company is headquartered in New York, NY. | Direttore Tecnico/Scientifico/R&S | - | - |
Formazione di David Lovejoy
| University of Victoria | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 3 |
| Canada | 3 |
Posizioni
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
| Corporate Officer/Principal | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| PROTAGENIC THERAPEUTICS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Protagenic Therapeutics, Inc. /Old/
Protagenic Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Protagenic Therapeutics, Inc. discovers and develops neuropeptides for the treatment of anxiety and depression based mood disorders. It focuses on the discovery and development of naturally occurring human brain hormones for the treatment of anxiety and depression based mood disorders. The firm products include PT00114 and PT00121, which are peptide-based formulations for the treatment of anxiety and depression disorders. The company is headquartered in New York, NY. | Health Technology |
- Borsa valori
- Insiders
- David Lovejoy
- Esperienza
